This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wistuba, I. I. Articles by Gazdar, A. F. Search for Related Content PubMed PubMed Citation Articles by Wistuba, I. I. Articles by Gazdar, A. F.

Genome-wide Allelotyping Analysis Reveals Multiple Sites of Allelic Loss in Gallbladder Carcinoma¹

Departments of Anatomic Pathology [I. I. W., M. T., H. A., P. T.] and Surgery [F. P.], P. Universidad Catolica de Chile, Santiago, Chile, and Hamon Center for Therapeutic Oncology Research and Department of Pathology, University of Texas, Southwestern Medical Center, Dallas, Texas 75390 [A. M., A. F. G.]

Although gallbladder carcinoma (GBC) is a highly malignant neoplasm, there is very limited information about the molecular changes involved in its pathogenesis. To identify the chromosomal locations of putative tumor suppressor gene loci involved in the pathogenesis of GBC, we conducted a genome-wide allelotyping or loss of heterozygosity (LOH) analysis of GBCs. Microdissected tissue from 24 archival GBCs and their matched control DNAs were analyzed for PCR-based LOH using 169 microsatellite markers spanning all nonacrocentric autosomal arms and the X chromosome. The chromosomal arms with the greatest frequencies of LOH (60%) were 3p, 6q, 7q, 8p, 9p, 9q, 11q, 12q, 17p, 18q, 19p, 22q, and Xq. The average fractional allele loss index in GBC cases was high (0.43) and frequent breakpoints were detected in gallbladder tumors. Of interest, 21 different regions of frequent LOH (hot spots) defined as 50% for individual GBC samples were detected in this neoplasm, nearly half of them confined to one microsatellite marker. We conclude that in GBC at least 21 chromosomal regions with frequent allele losses are involved, suggesting that several putative tumor suppressor genes are inactivated in its pathogenesis. Overall, these data provide global estimates of the extent of genetic changes leading to GBC and will be useful for the identification of new tumor suppressor genes and for multiple new markers for translational research.

This article has been cited by other articles:

				T. Takahashi, N. Shivapurkar, E. Riquelme, H. Shigematsu, J. Reddy, M. Suzuki, K. Miyajima, X. Zhou, B. N. Bekele, A. F. Gazdar, et al. Aberrant Promoter Hypermethylation of Multiple Genes in Gallbladder Carcinoma and Chronic Cholecystitis Clin. Cancer Res., September 15, 2004; 10(18): 6126 - 6133. [Abstract] [Full Text] [PDF]

				M. Tang, S. Baez, M. Pruyas, A. Diaz, A. Calvo, E. Riquelme, and I. I. Wistuba Mitochondrial DNA Mutation at the D310 (Displacement Loop) Mononucleotide Sequence in the Pathogenesis of Gallbladder Carcinoma Clin. Cancer Res., February 1, 2004; 10(3): 1041 - 1046. [Abstract] [Full Text] [PDF]

				T. Obata, M. Toyota, A. Satoh, Y. Sasaki, K. Ogi, K. Akino, H. Suzuki, M. Murai, T. Kikuchi, H. Mita, et al. Identification of HRK as a Target of Epigenetic Inactivation in Colorectal and Gastric Cancer Clin. Cancer Res., December 15, 2003; 9(17): 6410 - 6418. [Abstract] [Full Text] [PDF]

				C.-M. Wong, J. M.-F. Lee, Y.-P. Ching, D.-Y. Jin, and I. O.-l. Ng Genetic and Epigenetic Alterations of DLC-1 Gene in Hepatocellular Carcinoma Cancer Res., November 15, 2003; 63(22): 7646 - 7651. [Abstract] [Full Text] [PDF]

				A. Rashid, T. Ueki, Y.-T. Gao, P. S. Houlihan, C. Wallace, B.-S. Wang, M.-C. Shen, J. Deng, and A. W. Hsing K-ras Mutation, p53 Overexpression, and Microsatellite Instability in Biliary Tract Cancers: A Population-based Study in China Clin. Cancer Res., October 1, 2002; 8(10): 3156 - 3163. [Abstract] [Full Text] [PDF]

				E. Szabo, T. Carling, O. Hessman, and J. Rastad Loss of Heterozygosity in Parathyroid Glands of Familial Hypercalcemia with Hypercalciuria and Point Mutation in Calcium Receptor J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3961 - 3965. [Abstract] [Full Text] [PDF]

				I. I. Wistuba, R. Ashfaq, A. Maitra, H. Alvarez, E. Riquelme, and A. F. Gazdar Fragile Histidine Triad Gene Abnormalities in the Pathogenesis of Gallbladder Carcinoma Am. J. Pathol., June 1, 2002; 160(6): 2073 - 2079. [Abstract] [Full Text] [PDF]

				P. H. J. Riegman, L. J. Burgart, K. K. Wang, J. C. J. Wink-Godschalk, W. N. M. Dinjens, P. D. Siersema, H. W. Tilanus, and H. van Dekken Allelic Imbalance of 7q32.3-q36.1 during Tumorigenesis in Barrett's Esophagus Cancer Res., March 1, 2002; 62(5): 1531 - 1533. [Abstract] [Full Text] [PDF]